Search Results

Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis

Thermo Fisher Scientific recently launched the Thermo Scientific Orbitrap Isora mass spectrometer and Orbitrap Isora Pro mass spectrometer in Waltham, Massachusetts, USA. The company stated that these are its first Orbitrap instruments equipped with a dedicated isotope ratio analysis mode. The two mass spectrometers launched this time will form an integrated workflow together with the Thermo Scientific Vanquish Duo ultra-high performance liquid chromatography system and the new Isotope Discoverer software, providing molecular-level isotope ratio analysis capabilities to laboratories and researchers worldwide. Isotope ratio analysis can help researchers determine the source of compounds and their formation processes by measuring natural variations in isotopes within samples, helping...

2026-08-26

NuCube Energy and Canadian Nuclear Laboratories Launch Microreactor R&D Collaboration

NuCube Energy, Inc. announced on August 25 that it has initiated research and development activities under an agreement signed with Canadian Nuclear Laboratories (CNL). The two parties will conduct research on the NuCube reactor design, focusing on advancing data identification, modeling, and analysis efforts to support the validation of its microreactor technology. Under this R&D program, Canadian Nuclear Laboratories will validate existing experimental data and benchmark computational models used to predict heat pipe performance in high-temperature environments exceeding 900 degrees Celsius. The qualified experimental data provided by Canadian Nuclear Laboratories will be used to expand the NuCube computational mo...

2026-08-26

Molecular Partners Advances DLL3 Radiopharmaceutical MP0712 to Higher Dose Cohort

Swiss clinical-stage biotechnology company Molecular Partners AG recently announced its business progress and financial results for the first half of 2026. The company stated that its DLL3-targeting radioactive DARPin therapy MP0712 has advanced to the second therapeutic dose level in a U.S. multicenter Phase 1/2a clinical study, and patient enrollment for the new dose cohort is currently underway. MP0712 is a radiopharmaceutical targeting the tumor-associated antigen DLL3, carrying a therapeutic alpha-emitting radionuclide lead-212 (Pb-212) payload, co-developed by Molecular Partners and Orano Med, primarily for small cell lung cancer and other neuroendocrine tumors. According to the company's disclosure, the first dose cohort of MP0712...

2026-08-26

FSG to Provide Electrical and Control Systems Support for Oklo's Groves Isotope Test Reactor Project

American Facility Solutions Group, LLC (FSG) announced on August 25 that it will support Oklo's Groves Isotope Test Reactor project, providing electrical, instrumentation, control, testing, and verification-related work. According to reports, the Groves Isotope Test Reactor achieved first criticality on August 5, 2026, reaching a controlled, self-sustaining nuclear chain reaction. The reactor is the fifth reactor to achieve this milestone among projects authorized under the U.S. Department of Energy's Reactor Pilot Program, and the first to reach criticality on private land under the program. The low-power test reactor is designed to lay the foundation for domestic commercial isotope production...

2026-08-26

Guohe Series Nuclear Power Engineering Modular Quarterly Meeting and Construction Technology Innovation Application Exchange Conference Successfully Held in Qidong

On August 21, the Guohe Series Nuclear Power Engineering Modular Quarterly Meeting and Construction Technology Innovation Application Exchange Conference, hosted by Shanghai Nuclear Engineering Research and Design Institute (SNERDI) and organized by China Nuclear Industry Fifth Construction Co., Ltd. (CNF), was successfully held in Qidong, Jiangsu Province. Zhang Shoulong, Deputy General Manager and Safety Director of SNERDI, Li Jun, Deputy General Manager of China Nuclear Engineering Corporation (CNEC), and Liu Weihua, Chief Engineer of CNF, attended the meeting. More than 50 representatives from various nuclear power construction participating units gathered to discuss the innovation and practical application of nuclear power modular construction technology. At the meeting, the implementation of action items from the previous quarter was first reviewed, followed by progress reports on key work items including dry construction, plugging modularization, module design guidance manual, and multi-discipline shared rack design optimization. Each nuclear power project department then reported on quarterly work progress and subsequent work plans in turn; participating construction units including China Nuclear Industry 22nd Construction Co., Ltd., China Nuclear Industry 23rd Construction Co., Ltd., and CNF conducted thematic exchanges on modular construction, automatic welding technology, implementation of innovative technologies, and the "7050" plan (70% of all plant welding joints as prefabricated joints, and 50% of all plant prefabricated joints welded by automatic welding). Departments of SNERDI and participating partner units conducted in-depth discussions, exchanging views on key challenges in nuclear power modular construction and building consensus on technical breakthroughs. During the meeting, all attending representatives visited the Jiangsu Heneng Qidong Intelligent Manufacturing Base for on-site inspection, observing the intelligent manufacturing production line construction and gaining direct insight into the practical achievements of modular prefabrication and intelligent manufacturing processes. The meeting fully affirmed the phased achievements made by all participating units in the field of Guohe series nuclear power modular construction, pointed out that modular construction is a key driver for improving quality and efficiency in nuclear power engineering, and made arrangements for the next phase of work, emphasizing that all participating units should continue to deepen EC (Engineering-Construction) collaboration and integrated construction-installation development, and strengthen collaborative coordination to fully guarantee the high-quality construction of Guohe series nuclear power projects.

2026-08-26

South Korea's SEC Joins National R&D Project for Active Dose Distribution Control Radiotherapy Equipment

South Korean electron beam source technology company SEC announced on August 25 that it has been selected as a joint research institution for the world's best active dose distribution control radiotherapy machine R&D project, and will participate in the development of core technologies related to next-generation radiotherapy equipment. The project is a newly established task under the Global Flagship Medical Device R&D Program of the South Korean government's medical device R&D fund, with a duration of 6 years and 6 months, starting from July this year and planned to continue until December 2032. The total project budget is 35.2 billion KRW, of which 28 billion KRW is government funding. Radexel serves as the lead institution, with SEC participating as a joint research institution. Other participating organizations include the Korea Atomic Energy Research Institute, Korea Testing Laboratory...

2026-08-25

South Korean team develops biodegradable microgel for localized radiation therapy

Pusan National University announced on August 25 that a research team led by Professor Yang Seung-yun from the Department of Biomaterials Science, in collaboration with Professor Kim Hoon-soo from the Department of Dermatology and Professor Kim Geun-young from the Department of Nuclear Medicine at Pusan National University Hospital, as well as SNBIA Co., Ltd., has developed a precision localized radiation therapy technology based on biodegradable radioactive isotope materials for the treatment of refractory keloids that tend to recur after surgery. Conceptual diagram of precision treatment technology for refractory keloids. Provided by Pusan National University. Keloids are caused by abnormal proliferation of fibroblasts and excessive accumulation of collagen after skin injury. Existing treatment methods include surgery, steroid injections, laser therapy, etc., but...

2026-08-25

Novartis Files Localized Production Application in China for Lutetium [177Lu] Vipivotide Tetraxetan

On August 24, information on the website of the Center for Drug Evaluation (CDE) of China's National Medical Products Administration showed that Novartis' nuclear medicine product Lutetium [177Lu] Vipivotide Tetraxetan had a localized production application submitted in China. On the same day, two indications for the drug were proposed for priority review, and the relevant review matters may correspond to this localized production application. Lutetium [177Lu] Vipivotide Tetraxetan, namely 177Lu-PSMA-617, is a radioligand therapy (RLT) drug acquired by Novartis following its acquisition of Endocyte. The drug consists of a small-molecule compound targeting prostate-specific membrane antigen (PSMA) conjugated to the therapeutic radionuclide Lutetium-177. Upon entering the bloodstream, the drug binds to prostate cancer cells expressing PSMA, and...

2026-08-25

US Study Shows Inertial Fusion Implosions Can Tolerate Certain Asymmetries

Researchers at the Lawrence Livermore National Laboratory (LLNL) in the US have recently found that implosion designs for inertial fusion energy (IFE) can withstand considerable imperfections before performance degrades sharply. This result aids in the design of fuel targets for future fusion power plants, particularly in assessing the tolerance of target capsules to errors under high-frequency injection and laser-driven conditions. The study's simulation results show the density (top) and temperature (bottom) at the instant just before fusion reactions peak in an asymmetric implosion. The hottest spot coincides with the point of highest fuel density, indicating direct ignition of high-density fuel jets driven by asymmetry. The image was recently selected for the cover of Physics of Plasmas...

2026-08-25

Angolan Public Health and Medical Training Delegation Visits the Affiliated Hospital of Southwest Medical University, Focusing on Nuclear Medicine Diagnosis and Treatment Technologies

Recently, the "Angola Public Health and Medical Training Program," organized by the International Exchange Center of the Sichuan Provincial Health Commission, was held at the Affiliated Hospital of Southwest Medical University. An 18-member delegation comprising Angolan health administrators and medical personnel visited the hospital for exchange, with a focus on learning about the development and clinical application of nuclear medicine, urology, and other related disciplines. Jiang Yong, member of the Standing Committee of the Party Committee, Vice President of Southwest Medical University, and President of the Affiliated Hospital, welcomed the Angolan delegation and introduced the hospital's basic information. He stated that under the guidance of the Sichuan Provincial Health Commission, the hospital will leverage its disciplinary advantages as a university-affiliated hospital and a Sichuan Provincial Medical Center to carry out practical cooperation with Angola in talent cultivation, technical exchange, and hospital management.

2026-08-25

China's Nuclear Power Installed Capacity Up 8.5% Year-on-Year by End of July

On August 25, the National Energy Administration released national electricity statistics for January-July. By the end of July, the country's cumulative installed power generation capacity reached 4.08 billion kilowatts, up 11.0% year-on-year. Among this, nuclear power installed capacity stood at 66.14 million kilowatts, up 8.5% year-on-year. During January-July, the country added 3.62 million kilowatts of new nuclear power installed capacity. In the same period, the cumulative average utilization hours of power generation equipment nationwide were 1,671 hours, down 135 hours from the same period last year. The data also showed that by the end of July, thermal power installed capacity was 1.58 billion kilowatts, up 6.3% year-on-year; hydropower installed capacity was 456 million kilowatts, up 3.4% year-on-year; wind power installed capacity was 687 million kilowatts, up 19.5% year-on-year; solar power installed capacity was 1.288 billion kilowatts, up year-on-year...

2026-08-25

Angolan Delegation Attends U.S.-Africa Nuclear Energy Summit in Ghana

An Angolan delegation participated in the 2026 U.S.-Africa Nuclear Energy Summit (USANES 2026), held from August 19 to 21 in Accra, Ghana. The summit focused on discussions regarding the peaceful use of nuclear energy on the African continent, with key topics including nuclear workforce development, nuclear safety, regulatory frameworks, institutional capacity building, technological innovation, and international cooperation. According to a statement from the Angolan diplomatic mission in Ghana, the summit theme was "Building and Sustaining the African Nuclear Workforce," with participants including government representatives, experts, and international partners. The Angolan delegation was led by Angola's Ambassador to Ghana, Rui Orlando Xavier, along with representatives from the Americas Department at Angola's Ministry of Foreign Affairs...

2026-08-25

Russia and Algeria Advance Cooperation in Peaceful Uses of Nuclear Energy

August 22 news, Russian Ambassador to Algeria Alexey Solomatin said in an interview that Russia and Algeria are advancing cooperation in the field of peaceful uses of nuclear energy, with direct working contacts established between the relevant agencies of the two countries. Solomatin stated that cooperation between the two countries in this field is expanding. The basis for bilateral cooperation is the Intergovernmental Agreement on Cooperation in the Peaceful Uses of Nuclear Energy signed in 2014. In addition, Russia and Algeria signed the Roadmap for Cooperation in the Peaceful Uses of Nuclear Energy during the 2024 International Atomic Energy Expo (Atomexpo), outlining the main directions of bilateral cooperation. He noted that the practical implementation of the agreements will begin in 2...

2026-08-25

Ketterle Team: "Neutrino Laser" Based on Quantum-Entangled Atomic Clouds Theoretically Infeasible

Nobel laureate Wolfgang Ketterle and his team have conducted a theoretical examination of a neutrino laser concept and concluded that the scheme is fundamentally difficult to realize. The research findings have been published in *Physical Review Letters*. The concept was previously proposed by American physicists, with the core idea being the use of rubidium-87 atomic clouds or other unstable isotopes, placing them into specific quantum states to generate highly directional neutrino beams. According to the concept, if a neutrino source analogous to a laser could be constructed, it would help accelerate neutrino mass measurements and advance observational studies of the interconversion phenomena among different types of neutrinos. The Ketterle team's key focus this time was whether a large number of atoms could cooperatively emit neutrinos and other fermions, similar to the synchronized release of photons in a conventional laser.

2026-08-25

France Authorizes CEA to Dismantle the Pégase Research Reactor Facility at Cadarache

The French Official Journal published a decree on August 23 authorizing the French Alternative Energies and Atomic Energy Commission (CEA) to carry out dismantling operations on the Pégase (Pégase) nuclear facility located at the Cadarache site in Saint-Paul-lès-Durance, Bouches-du-Rhône department. The facility is classified as Basic Nuclear Installation No. 22 (INB 22). The decree specifies the implementation phases for the partial dismantling of the Pégase research reactor and authorizes the CEA to build the equipment required for the dismantling operations. Under the decree, the boundaries of the Pégase facility will be adjusted to provide the necessary space for the layout of dismantling equipment and the temporary storage of waste generated during the dismantling process. The dismantling scope covers the Pégase facility itself, including the main building housing the storage and treatment...

2026-08-25